Universal screening isn't cost-effective in detecting celiac disease

06/2/2013 | Family Practice News

Universal serologic screening for celiac disease among 12-year-olds was more costly and yielded no gains in long-term quality of life in relation with bone health compared with the standard selective screening, a study in the journal Clinical Gastroenterology and Hepatology showed. Researchers also said that universal serological screening can lead to negative outcomes from unneeded endoscopic evaluations of healthy people if screening is falsely positive.

View Full Article in:

Family Practice News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA